Literature DB >> 15999157

Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma.

Eduardo Cambruzzi1, Cláudio Galleano Zettler, Cláudio Osmar Pereira Alexandre.   

Abstract

To estimate the association between human papillomavirus (HPV) status and the expression of p53, Ki-67 and bcl-2 in cases of endocervical adenocarcinoma, and the relation with squamous intraepithelial lesions (SIL) and age, 229 cases were selected, treated between 1995 and 2003 in the Hospital Nossa Senhora da Conceiçao. All samples were evaluated by polymerase chain reaction to determine HPV status. Immunohistochemical technique was used to investigate the expression of p53, Ki-67 and bcl-2. The joint occurrence of endocervical adenocarcinoma and SIL were estimated too. In the 229 evaluated cases, 182 cases (79.48%) were associated with the presence of the HPV. The most common types were HPV18 (93 cases - 51.09%) and HPV16 (62 cases - 34.06%). Expression of Ki-67 (p=0.009) and the presence of SIL (p=0.018) were associated to HPV infection. Expression of p53 (p=0.647) and bcl-2 (p=0.671) were not related to HPV status. The mean age of the patients was 53.2 years, without clear correlation between age group and HPV (p=0.095). The presence of HPV, especially type 18 in endocervical adenocarcinoma suggests that this agent can be an important cofactor in the development and progression of glandular neoplasms of the uterine cervix. The joint occurrence of endocervical adenocarcinoma and SIL may support this hypothesis. HPV may promote an increased proliferation index in endocervical adenocarcinoma, shown by the expression of Ki-67.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15999157     DOI: 10.1007/BF02893378

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  49 in total

Review 1.  Binary (Bethesda) system for cervical precursor lesions: a histologic perspective.

Authors:  C P Crum
Journal:  Diagn Cytopathol       Date:  1995-12       Impact factor: 1.582

2.  International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas.

Authors:  A P Vizcaino; V Moreno; F X Bosch; N Muñoz; X M Barros-Dios; D M Parkin
Journal:  Int J Cancer       Date:  1998-02-09       Impact factor: 7.396

3.  Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.

Authors:  J V Lacey; L A Brinton; F M Abbas; W A Barnes; P E Gravitt; M D Greenberg; S M Greene; O C Hadjimichael; L McGowan; R Mortel; P E Schwartz; S G Silverberg; A Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-12       Impact factor: 4.254

4.  Mitotic activity and apoptosis in endocervical glandular lesions.

Authors:  Suzuko Moritani; Olga B Ioffe; Satoru Sagae; Laila Dahmoush; Steven G Silverberg; Takanori Hattori
Journal:  Int J Gynecol Pathol       Date:  2002-04       Impact factor: 2.762

5.  Prediction of 'high-risk' cervical papillomavirus infection by biopsy morphology.

Authors:  D W Franquemont; B E Ward; W A Andersen; C P Crum
Journal:  Am J Clin Pathol       Date:  1989-11       Impact factor: 2.493

6.  The topography and invasive potential of cervical adenocarcinoma in situ, with and without associated squamous dysplasia.

Authors:  T J Colgan; G M Lickrish
Journal:  Gynecol Oncol       Date:  1990-02       Impact factor: 5.482

7.  Apotosis-related proteins in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix.

Authors:  Tak-Hong Cheung; Tony Kwok-Hung Chung; Keith Wing-Kit Lo; Mei-Yung Yu; Stan Krajewski; John C Reed; Yick-Fu Wong
Journal:  Gynecol Oncol       Date:  2002-07       Impact factor: 5.482

8.  A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas.

Authors:  Yasuko Koyamatsu; Masatoshi Yokoyama; Yoshifumi Nakao; Kouichi Fukuda; Toshiaki Saito; Keita Matsukuma; Tsuyoshi Iwasaka
Journal:  Gynecol Oncol       Date:  2003-09       Impact factor: 5.482

9.  Monoclonal antibodies Ki-67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material.

Authors:  W G McCluggage; P Maxwell; H A McBride; P W Hamilton; H Bharucha
Journal:  Int J Gynecol Pathol       Date:  1995-07       Impact factor: 2.762

10.  Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection.

Authors:  Sonia Andersson; Barbro Larson; Anders Hjerpe; Claes Silfverswärd; Jan Sällström; Erik Wilander; Eva Rylander
Journal:  Acta Obstet Gynecol Scand       Date:  2003-10       Impact factor: 3.636

View more
  2 in total

Review 1.  Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis.

Authors:  Agustín Ciapponi; Ariel Bardach; Demián Glujovsky; Luz Gibbons; María Alejandra Picconi
Journal:  PLoS One       Date:  2011-10-04       Impact factor: 3.240

2.  Increased nuclear β-catenin expression in oral potentially malignant lesions: A marker of epithelial dysplasia.

Authors:  Montserrat Reyes; Gonzalo Rojas-Alcayaga; Andrea Maturana; Juan-Pablo Aitken; Carolina Rojas; Ana-Verónica Ortega
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.